Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Interpreting statistics in medical literature: a vade mecum for surgeons
Gueller U, Delong E. Interpreting statistics in medical literature: a vade mecum for surgeons. J Am Coll Surg 2004; 198:441-58.
Mar 1, 2004Interpreting statistics in medical literature: a vade mecum for surgeons
Mar 1, 2004J Am Coll Surg 2004; 198:441-58
Gueller Ulrich, Delong Elizabeth R
The relationship between surgeon and hospital volume and outcomes for shoulder arthroplasty
Jain N, Pietrobon R, Hocker S, Gueller U, Shankar A, Higgins L. The relationship between surgeon and hospital volume and outcomes for shoulder arthroplasty. J Bone Joint Surg Am 2004; 86-A:496-505.
Mar 1, 2004The relationship between surgeon and hospital volume and outcomes for shoulder arthroplasty
Mar 1, 2004J Bone Joint Surg Am 2004; 86-A:496-505
Jain Nitin, Pietrobon Ricardo, Hocker Shawn, Gueller Ulrich, Shankar Anoop, Higgins Laurence D
Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab
Weder P, Anliker M, Itin P, Bargetzi M. Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab. Dermatology 2004:3-281.
Feb 16, 2004Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab
Feb 16, 2004Dermatology 2004:3-281
Weder Patrik, Anliker Mark, Itin P, Bargetzi M
Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research
Bertoni F, Cotter F, Cavalli F, Zucca E, Auer R, Jones C, Baldini L, Ponzoni M, Bertolini F, Pichert G, Fey M, Cerny T, Ghielmini M, Schmitz S, Cogliatti S, Conconi A, Swiss Group for Clinical Cancer Research. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research. British journal of haematology 2004; 124:289-98.
Feb 1, 2004Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research
Feb 1, 2004British journal of haematology 2004; 124:289-98
Bertoni Francesco, Cotter Finbarr E, Cavalli Franco, Zucca Emanuele, Auer Rebecca, Jones Chris, Baldini Luca, Ponzoni Maurilio, Bertolini Francesco, Pichert Gabriella, Fey Martin, Cerny Thomas, Ghielmini Michele, Schmitz Shu-Fang Hsu, Cogliatti Sergio B, Conconi Annarita, Swiss Group for Clinical Cancer Research
The fibroblast: sentinel cell and local immune modulator in tumor tissue
Silzle T, Randolph G, Kreutz M, Kunz-Schughart L. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 2004; 108:173-80.
Jan 10, 2004The fibroblast: sentinel cell and local immune modulator in tumor tissue
Jan 10, 2004Int J Cancer 2004; 108:173-80
Silzle Tobias, Randolph Gwendalyn J, Kreutz Marina, Kunz-Schughart Leoni A
Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab
Weder P, Anliker M, Itin P, Bargetzi M. Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab. Dermatology (Basel, Switzerland) 2004; 208:281-3.
Jan 1, 2004Familial cutaneous mycosis fungoides: successful treatment with a combination of gemcitabine and alemtuzumab
Jan 1, 2004Dermatology (Basel, Switzerland) 2004; 208:281-3
Weder Patrik, Anliker M, Itin P, Bargetzi M
Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms
Prikler L, Scandella E, Men Y, Engeler D, Diener P, Gillessen Sommer S, Ludewig B, Schmid H. Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms - Cancer Testis Antigene (CTA) als mögliche Zielantigene. Aktuel Urol 2004; 35:326-330.
Jan 1, 2004Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms
Jan 1, 2004Aktuel Urol 2004; 35:326-330
Prikler Ladislav, Scandella Elke, Men Ying, Engeler Daniel, Diener Pierre-André, Gillessen Sommer Silke, Ludewig Burkhard, Schmid Hans-Peter
Management and costs of treating lung cancer patients in a university hospital
Dedes K, Szucs T, Bodis S, Jörger M, Lowy A, Russi E, Steinert H, Weder W, Stahel R. Management and costs of treating lung cancer patients in a university hospital. PharmacoEconomics 2004; 22:435-44.
Jan 1, 2004Management and costs of treating lung cancer patients in a university hospital
Jan 1, 2004PharmacoEconomics 2004; 22:435-44
Dedes Konstantin J, Szucs Thomas D, Bodis Stephan, Jörger Markus, Lowy Adam, Russi Erich W, Steinert Hans C, Weder Walter, Stahel Rolf A
Klangreisen und Todeslicht
Renz M. Klangreisen und Todeslicht - Mystik in der Begleitung Sterbender. Christ in der Gegenwart 2004; 56:389-390.
Jan 1, 2004Klangreisen und Todeslicht
Jan 1, 2004Christ in der Gegenwart 2004; 56:389-390
Renz Monika
Spirituelle Erfahrungen in Leid und Krankheit
Renz M. Spirituelle Erfahrungen in Leid und Krankheit. Studioheft ORF Vorarlberg 2004; 41:46-56.
Jan 1, 2004Spirituelle Erfahrungen in Leid und Krankheit
Jan 1, 2004Studioheft ORF Vorarlberg 2004; 41:46-56
Renz Monika
Der „myoklonische Status epilepticus“ nach kardiopulmonaler Reanimation
Thömke F, Marx J, Hundsberger T, Sauer O, Hägele-Link S, Weileman S. Der „myoklonische Status epilepticus“ nach kardiopulmonaler Reanimation. Intensivmedizin 2004; 41:592-597.
Jan 1, 2004Der „myoklonische Status epilepticus“ nach kardiopulmonaler Reanimation
Jan 1, 2004Intensivmedizin 2004; 41:592-597
Thömke Frank, Marx Jürgen, Hundsberger Thomas, Sauer Oliver, Hägele-Link Stefan, Weileman SL
Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations
Mueck A, Seeger H, Wallwiener D, Huober J. Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations. European journal of gynaecological oncology 2004; 25:699-701.
Jan 1, 2004Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations
Jan 1, 2004European journal of gynaecological oncology 2004; 25:699-701
Mueck A O, Seeger H, Wallwiener D, Huober Jens
Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau
Paepke S, Eiermann W, Wolf C, Huober J, Warm M, Blohmer J, Diedrich F, Fischer T, Pildner v Steinburg S, Schwarz-Böger U, Jacobs V, Harbeck N, Kiechle M. Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau. Geburtsh Frauenheilk 2004; 64:1290-1298.
Jan 1, 2004Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau
Jan 1, 2004Geburtsh Frauenheilk 2004; 64:1290-1298
Paepke S, Eiermann W, Wolf C, Huober Jens, Warm M, Blohmer J, Diedrich F, Fischer T, Pildner v Steinburg S, Schwarz-Böger U, Jacobs VR, Harbeck N, Kiechle M
Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik
Krainick-Strobel U, Bergmann A, Huober J, Wallwiener D. Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik. Geburtsh Frauenheilk 2004; 64:632-633.
Jan 1, 2004Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik
Jan 1, 2004Geburtsh Frauenheilk 2004; 64:632-633
Krainick-Strobel U, Bergmann A, Huober Jens, Wallwiener D
Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database
Gueller U, Hervey S, Purves H, Muhlbaier L, Peterson E, Eubanks S, Pietrobon R. Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg 2004; 239:43-52.
Jan 1, 2004Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database
Jan 1, 2004Ann Surg 2004; 239:43-52
Gueller Ulrich, Hervey Sheleika, Purves Harriett, Muhlbaier Lawrence H, Peterson Eric D, Eubanks Steve, Pietrobon Ricardo
Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer
Senn H, Thürlimann B, Goldhirsch A, Wood W, Gelber R, Coates A. Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer. Breast (Edinburgh, Scotland) 2003; 12:569-82.
Dec 1, 2003Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer
Dec 1, 2003Breast (Edinburgh, Scotland) 2003; 12:569-82
Senn H-J, Thürlimann Beat, Goldhirsch A, Wood W C, Gelber R D, Coates A S
The importance of evidence-based international consensus in the primary treatment of breast cancer--a periodic 'must'
Senn H, Thürlimann B. The importance of evidence-based international consensus in the primary treatment of breast cancer--a periodic 'must'. Breast (Edinburgh, Scotland) 2003; 12:349-50.
Dec 1, 2003The importance of evidence-based international consensus in the primary treatment of breast cancer--a periodic 'must'
Dec 1, 2003Breast (Edinburgh, Scotland) 2003; 12:349-50
Senn Hans-Jörg, Thürlimann Beat
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 2003; 89:2133-9.
Dec 1, 2003Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro
Dec 1, 2003Br J Cancer 2003; 89:2133-9
Koch S, Mayer F, Honecker F, Schittenhelm Marcus, Bokemeyer C
Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size
Viehl C, Harder F, Spichtin H, Terracciano L, Stammberger U, Eisner L, Gueller U, Marti W, Hamel C, Zuber M. Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surg 2003; 27:1285-90.
Nov 6, 2003Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size
Nov 6, 2003World J Surg 2003; 27:1285-90
Viehl Carsten T, Harder Felix, Spichtin Hans P, Terracciano Luigi, Stammberger Uz, Eisner Lukas, Gueller Ulrich, Marti Walter R, Hamel Christian T, Zuber Markus
Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women
Thürlimann B, Robertson J, Nabholtz J, Buzdar A, Bonneterre J, Arimidex Study Group. Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women. European journal of cancer (Oxford, England : 1990) 2003; 39:2310-7.
Nov 1, 2003Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women
Nov 1, 2003European journal of cancer (Oxford, England : 1990) 2003; 39:2310-7
Thürlimann Beat, Robertson J F R, Nabholtz J M, Buzdar A, Bonneterre J, Arimidex Study Group